Curemetrix

Curemetrix

curemetrix

Black Falcon is proud to be an integral investor in CureMetrix, a company focused on developing the next generation of medical image analysis technology that healthcare providers and patients can confidently rely on.

Employing a patent-pending algorithm,  an adjunct, precision tool for mammography is in development that will provide answers and results never before seen in breast cancer screening, with the potential to save  countless lives.

To learn more, please visit www.curemetrix.com